Cardiovascular adverse drug reaction associated with combined β- adrenergic and calcium entry-blocking agents

Journal of Cardiovascular Pharmacology

Volumn 35, Issue 4, 2000, Pages 556-559

  Edoute, Yeouda ^a   Nagachandran, Pradeep ^a   Svirski, Boris ^a   Ben Ami, Haim ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Adrenergic blocker; Adverse drug effects; Bradyarrhythmia; Calcium antagonist

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; PROPRANOLOL;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEART PACING; HUMAN; HYPERTENSION; INCIDENCE; MALE; PRIORITY JOURNAL; SINUS BRADYCARDIA;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; BRADYCARDIA; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; DRUG THERAPY, COMBINATION; ELECTROPHYSIOLOGY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0034087439     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200004000-00007     Document Type: Article

References (1)

1. Packer M, Leon MB, Bonow RO, et al. Hemodynamic and clinical effects of combined verapamil and propranolol therapy in angina pectoris. Am J Cardiol 1982;50:903-12.